Table 1. Tenofovir Disoproxil Fumarate Drug Substance Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Tenofovir Disoproxil Fumarate Drug Substance Market Restraints

Table 3. Tenofovir Disoproxil Fumarate Drug Substance Market Trends

Table 4. Tenofovir Disoproxil Fumarate Drug Substance Industry Policy

Table 5. Global Tenofovir Disoproxil Fumarate Drug Substance Revenue by Company, 2018-2023, US$ million

Table 6. Global Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share by Company, 2018-2023

Table 7. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Company, 2018-2023, (Tons)

Table 8. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share by Company, 2018-2023

Table 9. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Company, 2018-2023, (US$/Ton)

Table 10. Global Tenofovir Disoproxil Fumarate Drug Substance Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Tenofovir Disoproxil Fumarate Drug Substance Mergers & Acquisitions, Expansion Plans

Table 12. Global Tenofovir Disoproxil Fumarate Drug Substance Manufacturers Product Type

Table 13. China Tenofovir Disoproxil Fumarate Drug Substance Revenue by Company, 2018-2023, US$ million

Table 14. China Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share by Company, 2018-2023

Table 15. China Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Company, 2018-2023, (Tons)

Table 16. China Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Tenofovir Disoproxil Fumarate Drug Substance Production, Sales, Import and Export, 2018-2029, (Tons)

Table 18. China Tenofovir Disoproxil Fumarate Drug Substance Import & Export Trends

Table 19. Main Sources of China Tenofovir Disoproxil Fumarate Drug Substance Import

Table 20. Export Destination of China Tenofovir Disoproxil Fumarate Drug Substance

Table 21. Global Headquarters and Manufacturing Base of Tenofovir Disoproxil Fumarate Drug Substance Manufacturers

Table 22. Global Major Manufacturers, Tenofovir Disoproxil Fumarate Drug Substance Capacity Expansion and Future Plans

Table 23. Global Tenofovir Disoproxil Fumarate Drug Substance Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)

Table 24. Global Tenofovir Disoproxil Fumarate Drug Substance Production by Region, 2018-2023, (Tons)

Table 25. Global Tenofovir Disoproxil Fumarate Drug Substance Production Forecast by Region, 2023-2029, (Tons)

Table 26. Global Key Players of Tenofovir Disoproxil Fumarate Drug Substance Upstream (Raw Materials)

Table 27. Global Tenofovir Disoproxil Fumarate Drug Substance Typical Customers

Table 28. Tenofovir Disoproxil Fumarate Drug Substance Typical Distributors

Table 29. By Type, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Tenofovir Disoproxil Fumarate Drug Substance Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Table 34. By Country, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share, 2018-2029

Table 37. By Country, Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Table 38. By Country, Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2018-2029

Table 39. MACLEODS PHARMACEUTICALS LTD Company Information, Head Office, Market Area and Industry Position

Table 40. MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 41. MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 42. MACLEODS PHARMACEUTICALS LTD Company Profile and Main Business

Table 43. MACLEODS PHARMACEUTICALS LTD Recent Developments

Table 44. HETERO LABS LTD Company Information, Head Office, Market Area and Industry Position

Table 45. HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 46. HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 47. HETERO LABS LTD Company Profile and Main Business

Table 48. HETERO LABS LTD Recent Developments

Table 49. AUROBINDO PHARMA LTD Company Information, Head Office, Market Area and Industry Position

Table 50. AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 51. AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 52. AUROBINDO PHARMA LTD Company Profile and Main Business

Table 53. AUROBINDO PHARMA LTD Recent Developments

Table 54. MYLAN LABORATORIES LTD Company Information, Head Office, Market Area and Industry Position

Table 55. MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 56. MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 57. MYLAN LABORATORIES LTD Company Profile and Main Business

Table 58. MYLAN LABORATORIES LTD Recent Developments

Table 59. CIPLA LTD Company Information, Head Office, Market Area and Industry Position

Table 60. CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 61. CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 62. CIPLA LTD Company Profile and Main Business

Table 63. CIPLA LTD Recent Developments

Table 64. VIYASH LIFE SCIENCES PRIVATE LTD Company Information, Head Office, Market Area and Industry Position

Table 65. VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 66. VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 67. VIYASH LIFE SCIENCES PRIVATE LTD Company Profile and Main Business

Table 68. VIYASH LIFE SCIENCES PRIVATE LTD Recent Developments

Table 69. EMCURE PHARMACEUTICALS LTD Company Information, Head Office, Market Area and Industry Position

Table 70. EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 71. EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 72. EMCURE PHARMACEUTICALS LTD Company Profile and Main Business

Table 73. EMCURE PHARMACEUTICALS LTD Recent Developments

Table 74. STYRAX PHARMA PRIVATE LTD Company Information, Head Office, Market Area and Industry Position

Table 75. STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 76. STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 77. STYRAX PHARMA PRIVATE LTD Company Profile and Main Business

Table 78. STYRAX PHARMA PRIVATE LTD Recent Developments

Table 79. LAURUS LABS LTD Company Information, Head Office, Market Area and Industry Position

Table 80. LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 81. LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 82. LAURUS LABS LTD Company Profile and Main Business

Table 83. LAURUS LABS LTD Recent Developments

Table 84. AURISCO PHARMACEUTICAL CO LTD Company Information, Head Office, Market Area and Industry Position

Table 85. AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 86. AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 87. AURISCO PHARMACEUTICAL CO LTD Company Profile and Main Business

Table 88. AURISCO PHARMACEUTICAL CO LTD Recent Developments

Table 89. ACEBRIGHT INDIA PHARMA PRIVATE LTD Company Information, Head Office, Market Area and Industry Position

Table 90. ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 91. ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 92. ACEBRIGHT INDIA PHARMA PRIVATE LTD Company Profile and Main Business

Table 93. ACEBRIGHT INDIA PHARMA PRIVATE LTD Recent Developments

Table 94. SOLARA ACTIVE PHARMA SCIENCES LTD Company Information, Head Office, Market Area and Industry Position

Table 95. SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 96. SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 97. SOLARA ACTIVE PHARMA SCIENCES LTD Company Profile and Main Business

Table 98. SOLARA ACTIVE PHARMA SCIENCES LTD Recent Developments

Table 99. LUPIN LTD Company Information, Head Office, Market Area and Industry Position

Table 100. LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 101. LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 102. LUPIN LTD Company Profile and Main Business

Table 103. LUPIN LTD Recent Developments

Table 104. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Company Information, Head Office, Market Area and Industry Position

Table 105. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 106. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 107. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Company Profile and Main Business

Table 108. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Developments

Table 109. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Company Information, Head Office, Market Area and Industry Position

Table 110. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 111. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 112. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Company Profile and Main Business

Table 113. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Recent Developments

Table 114. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Company Information, Head Office, Market Area and Industry Position

Table 115. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 116. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 117. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Company Profile and Main Business

Table 118. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Developments

Table 119. SHANDONG ANHONG PHARMACEUTICAL CO LTD Company Information, Head Office, Market Area and Industry Position

Table 120. SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 121. SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 122. SHANDONG ANHONG PHARMACEUTICAL CO LTD Company Profile and Main Business

Table 123. SHANDONG ANHONG PHARMACEUTICAL CO LTD Recent Developments

Table 124. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Company Information, Head Office, Market Area and Industry Position

Table 125. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 126. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 127. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Company Profile and Main Business

Table 128. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Recent Developments

Table 129. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Company Information, Head Office, Market Area and Industry Position

Table 130. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Models, Specifications and Application

Table 131. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 132. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Company Profile and Main Business

Table 133. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Recent Developments

List of Figure

Figure 1. Tenofovir Disoproxil Fumarate Drug Substance Picture

Figure 2. By Revenue, Global Tenofovir Disoproxil Fumarate Drug Substance Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Tenofovir Disoproxil Fumarate Drug Substance Market Size and Forecast, 2018-2029, (Tons)

Figure 4. Global Tenofovir Disoproxil Fumarate Drug Substance Price Trend, 2018-2029, (US$/Ton)

Figure 5. By Revenue, China Tenofovir Disoproxil Fumarate Drug Substance Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Tenofovir Disoproxil Fumarate Drug Substance Market Size and Forecast, 2018-2029, (Tons)

Figure 7. China Tenofovir Disoproxil Fumarate Drug Substance Price Trend, 2018-2029 (US$/Ton)

Figure 8. By Revenue, China Tenofovir Disoproxil Fumarate Drug Substance Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Tenofovir Disoproxil Fumarate Drug Substance Share of Global Market, 2018-2029

Figure 10. Global Tenofovir Disoproxil Fumarate Drug Substance Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Tenofovir Disoproxil Fumarate Drug Substance Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Tenofovir Disoproxil Fumarate Drug Substance Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Tenofovir Disoproxil Fumarate Drug Substance Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Tenofovir Disoproxil Fumarate Drug Substance Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Tenofovir Disoproxil Fumarate Drug Substance Domestic VS Export, 2022

Figure 16. Global Tenofovir Disoproxil Fumarate Drug Substance Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Tenofovir Disoproxil Fumarate Drug Substance Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share & Forecast by Region, 2018-2029

Figure 19. Tenofovir Disoproxil Fumarate Drug Substance Industry Chain

Figure 20. Tenofovir Disoproxil Fumarate Drug Substance Procurement Model

Figure 21. Tenofovir Disoproxil Fumarate Drug Substance Sales Model

Figure 22. Tenofovir Disoproxil Fumarate Drug Substance Sales Channels, Direct Sales and Distribution

Figure 23. Purity≥99%

Figure 24. Purity<99%

Figure 25. By Type, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share, 2018-2029

Figure 27. By Type, Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Figure 28. By Type, Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Tenofovir Disoproxil Fumarate Drug Substance Price, 2018-2029, (US$/Ton)

Figure 30. Tablet

Figure 31. Granule

Figure 32. Capsule

Figure 33. Oral Powder

Figure 34. By Application, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue, 2018-2029, US$ Million

Figure 35. By Application, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share, 2018-2029

Figure 36. By Application, Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Figure 37. By Application, Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2018-2029

Figure 38. By Application, Global Tenofovir Disoproxil Fumarate Drug Substance Price, 2018-2029, (US$/Ton)

Figure 39. By Region, Global Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share, 2018-2029

Figure 40. By Region, Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2018-2029

Figure 41. North America Tenofovir Disoproxil Fumarate Drug Substance Revenue & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, North America Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share, 2022

Figure 43. Europe Tenofovir Disoproxil Fumarate Drug Substance Revenue & Forecasts, 2018-2029, US$ Million

Figure 44. By Country, Europe Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share, 2022

Figure 45. Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country/Region, Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share, 2022

Figure 47. South America Tenofovir Disoproxil Fumarate Drug Substance Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. By Country, South America Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share, 2022

Figure 49. Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Revenue & Forecasts, 2018-2029, US$ Million

Figure 50. U.S. Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Figure 51. By Company, U.S. Tenofovir Disoproxil Fumarate Drug Substance Market Share, 2022

Figure 52. By Type, U.S. Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 53. By Application, U.S. Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 54. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Figure 55. By Company, Europe Tenofovir Disoproxil Fumarate Drug Substance Market Share, 2022

Figure 56. By Type, Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 57. By Application, Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 58. China Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Figure 59. By Company, China Tenofovir Disoproxil Fumarate Drug Substance Market Share, 2022

Figure 60. By Type, China Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 61. By Application, China Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 62. Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Figure 63. By Company, Japan Tenofovir Disoproxil Fumarate Drug Substance Market Share, 2022

Figure 64. By Type, Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 65. By Application, Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 66. South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Figure 67. By Company, South Korea Tenofovir Disoproxil Fumarate Drug Substance Market Share, 2022

Figure 68. By Type, South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 69. By Application, South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 70. Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Figure 71. By Company, Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Market Share, 2022

Figure 72. By Type, Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 73. By Application, Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 74. India Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Figure 75. By Company, India Tenofovir Disoproxil Fumarate Drug Substance Market Share, 2022

Figure 76. By Type, India Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 77. By Application, India Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 78. Middle East & Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2018-2029, (Tons)

Figure 79. By Company, Middle East & Asia Tenofovir Disoproxil Fumarate Drug Substance Market Share, 2022

Figure 80. By Type, Middle East & Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 81. By Application, Middle East & Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share, 2022 VS 2029

Figure 82. Research Methodology

Figure 83. Breakdown of Primary Interviews

Figure 84. Bottom-up Approaches

Figure 85. Top-down Approaches